Paola Di Benedetto
L'aquila, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center.
Journal: The Journal of rheumatology
Published: October 04, 2021
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis.
Journal: Frontiers in immunology
Published: March 26, 2021
Endothelial-to-mesenchymal transition in systemic sclerosis.
Journal: Clinical and experimental immunology
Published: January 27, 2021
The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile.
Journal: Scientific reports
Published: January 05, 2021
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis.
Journal: Arthritis research & therapy
Published: December 21, 2020
Response to: 'Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al' by Chen et al.
Journal: Annals of the rheumatic diseases
Published: August 25, 2020
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences.
Journal: Annals of the rheumatic diseases
Published: May 19, 2020
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm.
Journal: Frontiers in immunology
Published: April 06, 2020
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations.
Journal: Scientific reports
Published: March 31, 2020
Haematopoietic stem cell transplantation in systemic sclerosis: Challenges and perspectives.
Journal: Autoimmunity reviews
Published: March 31, 2020
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension.
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension.
Journal: Arthritis research & therapy
Published: February 14, 2020
Last Updated: 09/26/2026